5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy—A randomised study
Authors:
- Timo T. MuhonenTMTimo T. Muhonen
- Vesa V. KatajaVKVesa V. Kataja
- Martti K. FlanderMFMartti K. Flander
- Lasse TeerenhoviLTLasse Teerenhovi
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer
- Vol. 29 (12) , 1669-1672
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapyThe Lancet, 1991
- Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1991
- Antiemetic action of 5-HT3 receptor antagonists: review of preclinical and clinical results with ICS 205–930Cancer Treatment Reviews, 1990
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- Identification and distribution of 5-HT3 receptors in rat brain using radioligand bindingNature, 1987
- Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonismBritish Journal of Pharmacology, 1986
- Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugsNature, 1985
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Blockade of neuronal tryptamine receptors by metoclopramideEuropean Journal of Pharmacology, 1978